|
Dr. Meretzki received his PhD. in biotechnology from the Technion Israel Institute of Technology. His research work was conducted at the Technion Israel Institute of Technology in cooperation with the Weizmann Institute of Science, under the supervision of renowned scientists, Dr. Avinoam Kadouri, Prof. Dov Zipori and Dr. Shosh Merchav, marking the launching of developmental work on the bioreactor. Dr. Meretzki holds PluriX technology patent. Dr. Meretzki is also a chemical engineer and has performed extensive biological and chemical R&D for various companies and organizations in Israel.
Dr Meretzki major research subjects are Cord Blood Biology, hematopoietic stem cells biology, mesanchemal stem cells, scaffold design and bioreactors technologies.
Dr Meretzki is a member of; the American Society of Hematology, the international society of cellular therapy and The European Hematology Association (EHA) ,the International Society for Experimental Hematology, The International Society for Stem Cell Research other organizations | 